4.3 Article

Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma

期刊

LEUKEMIA RESEARCH
卷 37, 期 9, 页码 1120-1124

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2013.05.003

关键词

JAK/STAT signaling pathway; Non-Hodgkin lymphoma; Polymorphism; Case-control study

资金

  1. NIH [CA62006, CA165923, 1D43TW008323, 1D43TW007864, HD70324]
  2. Intramural Research Program of the National Cancer Institute

向作者/读者索取更多资源

Impaired function of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway genes leads to immunodeficiency and various hematopoietic disorders. We evaluated the association between genetic polymorphisms (SNPs) in 12 JAK/STAT pathway genes (JAK3, STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, STAT6, SCOS1, SCOS2, SCOS3, and SCOS4) and NHL risk in a population-based case-control study of Connecticut women. We identified three SNPs in STAT3 (rs12949918 and rs6503695) and STAT4 (rs932169) associated with NHL risk after adjustment for multiple comparison. Our results suggest that genetic variation in JAK/STAT pathway genes may play a role in lymphomagenesis and warrants further investigation. (C) 2013 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据